Sneak Peek into AMP Europe
+
Available Dates
30 September-2 October 2024 | Amsterdam, The Netherlands |
Accreditation
Please see Accreditation Below
Intended Learners
AMP Europe is designed for interventional cardiologists, vascular surgeons, interventional radiologists, wound care specialists, podiatrists, nurses, vascular technologists, and cardiovascular catheterization laboratory team members.
Learning Objectives
After attending AMP, participants should be able to:
- Apply a comprehensive, multidisciplinary best practice approach for patients with advanced peripheral arterial disease (PAD) and critical limb ischemia (CLI) at risk for major amputation
- Describe arterial angiosome anatomy in conjunction with cutaneous and ultrasonic angiosome mapping in patients with advanced tibio-pedal arterial disease at risk for major amputation
- Describe the surgical approach to post-revascularization limb salvage for patients with CLI at risk for major amputation
- Implement a diagnostic algorithm which includes selective angiography as a critical step for patients with CLI who are at risk for amputation
- Incorporate advanced tibio-pedal access in combination with antegrade access in limb salvage procedures
- Utilize digital branch access during CLI interventions
- Implement transcollateral interventions in below-the-knee and below-the-ankle interventions
- Describe tips and tricks for safe and effective surgical and endovascular treatment of CLI from access to closure
- Describe unique considerations when evaluating the diabetic foot ulcer in the setting of CLI
- Describe the current state of wound oriented revascularization in the patient with CLI
- Describe the algorithm to identify and treat mixed arterial and venous wounds in the patient with CLI
- Describe when to refer the patient with CLI and osteomyelitis for an ID consult
- Describe when to urgently refer a patient with CLI and wounds to a wound care specialist
- Describe when to urgently refer a patient post-revascularization back to the revascularization specialist
- Describe current medical management of the patient with advanced PAD or CLI
- Describe currently available drug-eluting technology for the treatment of above-the-knee and below-the-knee lesions in the patient with CLI
- Describe current wire, catheter, balloon, crossing, atherectomy, re-entry, and closure devices available for treatment of CLI, and describe mechanism of action and when most appropriate to utilize
- Describe the role of atherectomy in CLI and its application in amputation prevention Treat complex chronic total occlusions in tibial and pedal arterial vessels in the patient with CLI
- Implement procedural and technological advances in wound care practices for patients facing major amputation due to advanced PAD, advanced non-healing wounds, and gangrene
Accreditation Information
UEMS-EACCME®
AMP Europe (with the Event code: LEE/2024/01201) has been granted 15 European CME credits (ECMEC®s) by the European Accreditation Council for Continuing Medical Education (EACCME®). The event is now posted in the list of accredited events on www.eaccme.eu.
Please see Accreditation Below
Intended Learners
AMP Europe is designed for interventional cardiologists, vascular surgeons, interventional radiologists, wound care specialists, podiatrists, nurses, vascular technologists, and cardiovascular catheterization laboratory team members.
Learning Objectives
After attending AMP, participants should be able to:
- Apply a comprehensive, multidisciplinary best practice approach for patients with advanced peripheral arterial disease (PAD) and critical limb ischemia (CLI) at risk for major amputation
- Describe arterial angiosome anatomy in conjunction with cutaneous and ultrasonic angiosome mapping in patients with advanced tibio-pedal arterial disease at risk for major amputation
- Describe the surgical approach to post-revascularization limb salvage for patients with CLI at risk for major amputation
- Implement a diagnostic algorithm which includes selective angiography as a critical step for patients with CLI who are at risk for amputation
- Incorporate advanced tibio-pedal access in combination with antegrade access in limb salvage procedures
- Utilize digital branch access during CLI interventions
- Implement transcollateral interventions in below-the-knee and below-the-ankle interventions
- Describe tips and tricks for safe and effective surgical and endovascular treatment of CLI from access to closure
- Describe unique considerations when evaluating the diabetic foot ulcer in the setting of CLI
- Describe the current state of wound oriented revascularization in the patient with CLI
- Describe the algorithm to identify and treat mixed arterial and venous wounds in the patient with CLI
- Describe when to refer the patient with CLI and osteomyelitis for an ID consult
- Describe when to urgently refer a patient with CLI and wounds to a wound care specialist
- Describe when to urgently refer a patient post-revascularization back to the revascularization specialist
- Describe current medical management of the patient with advanced PAD or CLI
- Describe currently available drug-eluting technology for the treatment of above-the-knee and below-the-knee lesions in the patient with CLI
- Describe current wire, catheter, balloon, crossing, atherectomy, re-entry, and closure devices available for treatment of CLI, and describe mechanism of action and when most appropriate to utilize
- Describe the role of atherectomy in CLI and its application in amputation prevention Treat complex chronic total occlusions in tibial and pedal arterial vessels in the patient with CLI
- Implement procedural and technological advances in wound care practices for patients facing major amputation due to advanced PAD, advanced non-healing wounds, and gangrene
Accreditation Information
UEMS-EACCME®
AMP Europe (with the Event code: LEE/2024/01201) has been granted 15 European CME credits (ECMEC®s) by the European Accreditation Council for Continuing Medical Education (EACCME®). The event is now posted in the list of accredited events on www.eaccme.eu.